España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
SciSparc
SPRC
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.673000
0.03
4.67%
At Close: -
$0.650200
-0.02
-3.39%
After Hours: 5:13 PM EDT
15 minutes delayed
Get Report
Comment
SciSparc (SPRC) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for SciSparc (NASDAQ:SPRC) Stock
SciSparc Stock (NASDAQ: SPRC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, July 22, 2024
SciSparc Announces MitoCareX Confirms Potenti...
Benzinga Newsdesk
Wednesday, July 17, 2024
SciSparc Announced That It Has Signed A Non-b...
Benzinga Newsdesk
Tuesday, July 16, 2024
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
SciSparc Receives Notification From Nasdaq Re...
Benzinga Newsdesk
Thursday, July 11, 2024
Why WD-40 Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, July 08, 2024
SciSparc shares are trading higher after the ...
Benzinga Newsdesk
SciSparc Signs Non-Binding Letter Of Intent T...
Benzinga Newsdesk
Friday, May 31, 2024
SciSparc Says European Patent Office Granted ...
Benzinga Newsdesk
Tuesday, April 16, 2024
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Thursday, April 11, 2024
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
SciSparc To Acquire AutoMax, A Strategic Leap Towards Industry Diversification
Akanksha Bakshi
SciSparc shares are trading higher. The compa...
Benzinga Newsdesk
SciSparc To Acquire AutoMax, Terms Not Disclo...
Benzinga Newsdesk
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, April 09, 2024
SciSparc Granted Canadian Patent #2984088 Tit...
Benzinga Newsdesk
Wednesday, March 27, 2024
SciSparc- Clearmind Collaboration Evolves Wit...
Benzinga Newsdesk
Thursday, March 21, 2024
SciSparc shares are trading higher after the ...
Benzinga Newsdesk
SciSparc Announces MitoCareX Unveils Groundbr...
Benzinga Newsdesk
Monday, March 18, 2024
SciSparc Bags Another Patent, Strengthening i...
Benzinga Newsdesk
Thursday, March 14, 2024
SciSparc Achieves Major Milestone With First ...
Benzinga Newsdesk
Tuesday, March 12, 2024
Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors
Lara Goldstein
SciSparc and MitoCareX Bio Discover Potential...
Benzinga Newsdesk
Friday, March 08, 2024
Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments
Jelena Martinovic
SciSparc Discloses Enrollment Of First Patien...
Benzinga Newsdesk
Thursday, March 07, 2024
SciSparc Announced That The Process Of Granti...
Benzinga Newsdesk
Wednesday, March 06, 2024
SciSparc Issued Canadian Patent For Opioids R...
Benzinga Newsdesk
SciSparc Has Received A Decision To Grant Eur...
Benzinga Newsdesk
Monday, March 04, 2024
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Lara Goldstein
Thursday, February 29, 2024
SciSparc Delivers Treatment For Autism Spectr...
Benzinga Newsdesk
Tuesday, February 27, 2024
EXCLUSIVE: Psychedelic-Focused Firm Clearmind Medicine Submits Three New International Patent Applications For MDMA, Ibogaine And Ketamine Compounds
Vandana Singh
Wednesday, February 21, 2024
Next-Gen Psychedelics Companies SciSparc And Clearmind Collaboration File 3 Patents
Patricio Liddle
Tuesday, February 20, 2024
What's Going On With Psychedelic Drug-Developers SciSparc And Clearmind Stock?
Erica Kollmann
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
SciSparc Shares Resume Trade After Circuit Br...
Benzinga Newsdesk
Market-Moving News for February 20th
Benzinga Newsdesk
Clearmind Medicine Submits Three Internationa...
Benzinga Newsdesk
Monday, February 12, 2024
SciSparc Said On February 5, Received Written Notice From Dekel Pharmaceuticals For Termination Of The License Agreement Dated May 20, 2015; Scisparc SaidCompany Disagrees And Rejects Dekel's Allegations As Set Forth In The Notice
Charles Gross
Monday, January 29, 2024
SciSparc Has Initiated Patient Recruitment Fo...
Benzinga Newsdesk
Friday, January 26, 2024
Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
Lara Goldstein
Wednesday, January 24, 2024
Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Crude Oil Rises Over 1%; DuPont Shares Plunge
Avi Kapoor
SciSparc shares are trading higher after the ...
Benzinga Newsdesk
Why SciSparc Stock Is Lighting Up
Erica Kollmann
SciSparc Shares Resume Trade
Benzinga Newsdesk
SciSparc Shares Resume Trade Then Again Halt ...
Benzinga Newsdesk
SciSparc Shares Halted On Circuit Breaker To ...
Benzinga Newsdesk
Dow Jumps 100 Points; Netflix Reports Strong Q4 Sales
Avi Kapoor
Market-Moving News for January 24th
Benzinga Newsdesk
SciSparc Reveals $20M Standby Equity Purchase...
Benzinga Newsdesk
Show More